Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)
China flag China · Delayed Price · Currency is CNY
15.96
+0.03 (0.19%)
Feb 4, 2026, 3:04 PM CST

SHE:300519 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
256.95267.54270.28351.37320.77282.96
Other Revenue
0.120.120.110.120.110.12
257.07267.66270.4351.49320.88283.08
Revenue Growth (YoY)
-4.96%-1.01%-23.07%9.54%13.35%-2.81%
Cost of Revenue
162.7177.89160.03169.81145.29128.68
Gross Profit
94.3789.77110.37181.68175.58154.4
Selling, General & Admin
40.3341.543.6450.6149.2746.59
Research & Development
13.0512.6215.1315.5513.5212.01
Other Operating Expenses
3.763.53.434.264.224.07
Operating Expenses
56.8957.7461.5170.8666.8562.71
Operating Income
37.4832.0348.87110.82108.7391.69
Interest & Investment Income
29.5823.5522.9814.0923.0319.29
Other Non Operating Income (Expenses)
0.69-0.01-0.02-0.01-0.012.74
EBT Excluding Unusual Items
67.7555.5771.83124.9131.74113.72
Gain (Loss) on Sale of Assets
-0.02-0.07-0.29--0.71-
Asset Writedown
0.14-0.010.020-0.02-0.45
Other Unusual Items
0.081.511.60.70.951.52
Pretax Income
67.9557.0173.16125.6131.96114.8
Income Tax Expense
10.016.628.816.7817.6815.82
Net Income
57.9450.3964.36108.82114.2898.98
Net Income to Common
57.9450.3964.36108.82114.2898.98
Net Income Growth
33.39%-21.70%-40.86%-4.78%15.46%5.41%
Shares Outstanding (Basic)
166163161160161160
Shares Outstanding (Diluted)
166163161160161160
Shares Change (YoY)
3.71%1.03%0.54%-0.58%0.83%0.30%
EPS (Basic)
0.350.310.400.680.710.62
EPS (Diluted)
0.350.310.400.680.710.62
EPS Growth
28.62%-22.50%-41.18%-4.23%14.52%5.08%
Free Cash Flow
64.5848.2337.3109.78127.64102.34
Free Cash Flow Per Share
0.390.300.230.690.790.64
Dividend Per Share
0.3000.3000.4000.5000.6000.600
Dividend Growth
-25.00%-25.00%-20.00%-16.67%-33.33%
Gross Margin
36.71%33.54%40.82%51.69%54.72%54.54%
Operating Margin
14.58%11.97%18.07%31.53%33.88%32.39%
Profit Margin
22.54%18.83%23.80%30.96%35.62%34.96%
Free Cash Flow Margin
25.12%18.02%13.80%31.23%39.78%36.15%
EBITDA
52.5346.9763.64124.88121.59104.22
EBITDA Margin
20.43%17.55%23.54%35.53%37.89%36.82%
D&A For EBITDA
15.0514.9314.7714.0512.8612.53
EBIT
37.4832.0348.87110.82108.7391.69
EBIT Margin
14.58%11.97%18.07%31.53%33.88%32.39%
Effective Tax Rate
14.73%11.61%12.03%13.36%13.40%13.78%
Revenue as Reported
257.07267.66270.4351.49320.88283.08
Source: S&P Global Market Intelligence. Standard template. Financial Sources.